These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3672439)

  • 1. Effect of leupeptin on platelet aggregation, fibrin formation and amidolysis induced by thrombin.
    Ruda EM; Scrutton MC
    Thromb Res; 1987 Sep; 47(5):611-9. PubMed ID: 3672439
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of a calcium dependent protease inhibitor on platelet activation and secretion.
    Rao GH; White JG; Cox CA
    Thromb Res; 1987 Sep; 47(6):625-37. PubMed ID: 3686479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin; a role for proteolytic activation of phospholipase C.
    Ruggiero M; Lapetina EG
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1198-205. PubMed ID: 4052085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of thrombin-induced platelet activation by leupeptin. Implications for the participation of calpain in the initiation of platelet activation.
    Brass LF; Shattil SJ
    J Biol Chem; 1988 Apr; 263(11):5210-6. PubMed ID: 2833498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipain or leupeptin in combination with aspirin or indomethacin synergistically inhibit human platelet activation by thrombin and trypsin.
    Ruggiero M; Lapetina EG
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():563-8. PubMed ID: 2959114
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leupeptin does not affect the normal signal transduction mechanism in platelets.
    Alonso MT; Sanchez A; Herreros B
    FEBS Lett; 1989 Feb; 244(2):407-10. PubMed ID: 2920837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained proteolysis is required for human platelet activation by thrombin.
    Ruggiero M; Lapetina EG
    Thromb Res; 1986 Apr; 42(2):247-55. PubMed ID: 3715802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation in prothrombin-complex-preparations; its effect on a chromogenic substrate, fibrinogen and platelets.
    Kirchhof B; Söntgerath D; Kirchhof U; Etscheid G
    Thromb Res; 1990 Aug; 59(3):541-51. PubMed ID: 2237826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the thrombin-platelet reactions by DuP 714.
    Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of activated protein C on platelet aggregation induced by the prothrombin-converting reaction.
    Komoriya K; Inoue K; Takahashi K; Suzuki K
    Thromb Res; 1992 Sep; 67(6):705-10. PubMed ID: 1440535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of fibrinogen receptor expression and serotonin release by leupeptin and antipain.
    Baldassare JJ; Bakshian S; Knipp MA; Fisher GJ
    J Biol Chem; 1985 Sep; 260(19):10531-5. PubMed ID: 2993278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet factor XIII is activated by calpain.
    Ando Y; Imamura S; Yamagata Y; Kitahara A; Saji H; Murachi T; Kannagi R
    Biochem Biophys Res Commun; 1987 Apr; 144(1):484-90. PubMed ID: 2883970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine.
    Nylander M; Lindahl TL; Bengtsson T; Grenegård M
    Platelets; 2008 Aug; 19(5):352-8. PubMed ID: 18791941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors.
    Puri RN; Colman RW
    Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
    Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-induced platelet reactions: effect of substrates and inhibitors on binding of thrombin and serotonin release.
    Iwamoto M; Blombäck B
    Thromb Res; 1984 Feb; 33(4):427-37. PubMed ID: 6538704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.